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Indication for pharmacological treatment is
often lacking: a cross-sectional study on the
quality of drug therapy among the elderly
Jessica Skoog1*, Patrik Midlöv1, Anders Beckman1, Jan Sundquist1,2 and Anders Halling1,3
Abstract
Background: Although the elderly have a substantially higher drug use than younger patients, even after
adjustment for multimorbidity, there is limited knowledge about the elderly’s indication for treatment. It is
essential for elderly patients to have a well-planned drug therapy. The first step towards a correct and safe drug
therapy is to ensure that the patient’s drugs have an indication, i.e. correct diagnoses are linked to all of the
prescription drugs. The aim of this study was to examine to what extent elderly patients have indication for a
number of their prescribed drugs and, furthermore, if there are any differences in indication for treatment
depending on gender, age, level of multimorbidity and income.
Method: Data were collected on individuals aged 65 years or older in Östergötland County in Sweden. To
estimate the individual level of multimorbidity the Johns Hopkins ACG Case-Mix System was used. A report
from the Swedish National Board of Health and Welfare was used to identify prescription drugs, for which it is
important to have a correct diagnosis. The proportions of patients having indication for these prescription drugs
were calculated. Odds ratios of having indication for treatment depending on gender, age, multimorbidity level
and income were calculated.
Results: On average 45.1 % (range 12.9 % – 75.8 %) of the patients’ prescribed drugs had indication. Proton
pump inhibitors were associated with the lowest level of indication (12.9 %) and digoxin was associated with the
highest level of indication for treatment (75.8 %). Patients aged 80 years or older had the lowest odds ratios of
having indication for treatment.
Conclusion: On average, there was indication for treatment in less than half of the prescription drugs studied.
The quality was highest in relation to multimorbidity and lowest in relation to age. The result may to some
extent be explained by substandard registration of diagnoses. Since lack of quality of prescription drug use is
highly associated with inconvenience among the elderly, as well as high costs to society, it is important that
future research and allocation of resources focus on the quality of elderly patients’ drug therapy.
Keywords: Pharmacological treatment, Drug therapy, Elderly patients, Aged patients, Indication, Prescription
drugs, Potential inappropriate medicine, Discontinue treatment
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Background
The population in the Western countries is ageing [1].
Chronic illness is more common at older age [2] and is
often associated with increased pharmacological treat-
ment among the elderly [3]. After adjustment for multi-
morbidity level the use of prescription drugs has been
shown to still be substantially higher among older pa-
tients compared to younger [4]. There are at least two
reasons for a remaining age difference after adjustment
for multimorbidity level: 1. Medical reasons like progres-
sion of diseases not reflected by the labelling of the diag-
nosis, for example diabetes and heart failure [5, 6], 2.
‘The prescribing cascade’ which is described as side ef-
fects of a prescription drug, which are misinterpreted as
a new medical condition leading to prescription of a
new drug [7]. An additional explanation could be that
the use of prescription drugs is not properly planned,
evaluated and discontinued among the elderly patients,
which may lead to an unnecessarily high use of prescrip-
tion drugs.
Treatment of elderly patients with prescription drugs
puts high demands on the prescribers. Changes in
pharmacokinetics and pharmacodynamics make elderly
patients more sensitive to side effects [8]. The elderly
patients often use many prescription drugs, and this in-
creases the risk of adverse drug reactions [9]. Because of
the above it is essential that elderly patients have a well-
thought-out pharmacological treatment. Already in the
1980s, WHO started their work on improving the
pharmacological treatment among elderly patients, and
in 1997 the first report was published on this topic [10].
One of the first steps towards the correct and safe use of
prescription drugs among elderly patients is to ensure
that the prescription drugs used by the patients have an
indication, i.e. correct diagnoses are linked to all of the
prescription drugs [10]. In order to improve the quality
of prescription drug use among elderly patients, efforts
have been made to define criteria for appropriate pre-
scription drug use. The most widespread criteria are
American Geriatrics Society Beers Criteria for Poten-
tially Inappropriate Medication Use in Older Adults
(Beers Criteria) [11]. The Beers Criteria serve as a guide
to physicians and list potential inappropriate medica-
tions that ought to be avoided among elderly patients to
reduce polypharmacy and adverse drug reactions. How-
ever, many of the listed prescription drugs in the Beers
Criteria are not available in Europe, and prescribing be-
haviour and clinical guidelines differ from the USA.
Therefore, many European countries have developed cri-
teria of their own [12–14]. In Sweden, the National
Board of Health and Welfare authored a report about
satisfactory pharmacological treatment among elderly
patients [15]. One of the aims of the report was to serve
as support to physicians when prescribing drugs to
elderly patients. Among other things the report resulted
in a list of prescription drugs, for which it is particularly
important to have accurate and up-to-date diagnoses,
see Table 1.
The main objective of this study was to examine to
what extent elderly patients have diagnoses linked to a
number of their prescription drugs, i.e. indication for
treatment, identified by the Swedish National Board of
Health and Welfare as potential inappropriate medica-
tion. Since former research has shown that females,
elderly, multimorbid patients and patients with low so-
cioeconomic status use more prescription drugs and
have higher levels of polypharmacy [3, 16, 17], we also
wanted to examine whether there are any differences in
having indication for these prescription drugs according
to gender, age, level of multimorbidity and income.
Methods
Study population
Data were collected from the total population aged
65 years or older in Östergötland County in Sweden,
having about 400 000 residents in 2006. Östergötland is
situated 200 km southwest of Stockholm, and the age
demographics match that of the rest of Sweden [18].
Data were obtained from the Care Data Warehouse in
Östergötland (CDWÖ), a register containing information
on both public and private care. The CDWÖ register
was established in 1998 and contain data on the patients’
diagnoses according to ICD-10, personal identification
number and healthcare unit visited from each consult-
ation, i.e. visits at PHCs, hospitals and inpatient care, in
Östergötland County. Data are transferred from
Östergötland County to the CDWÖ register once every
month. Data from the CDWÖ register were collected
during 2005–2006. This register has been described pre-
viously [19]. The study was approved by the research
ethics committee at Linköping University (approval
numbers 147/05 and 29/06).
Table 1 Prescription drugs for which an accurate and up-to-
date diagnosis is particularly important in elderly patientsa
Prescription drugs
Antipsychotic drugs
Proton pump inhibitors
Digoxin
Loop diuretics
Serotonin reuptake inhibitors
Cox-inhibitors (NSAIDs)
Paracetamol
Opioids
aAccording to the Swedish National Board of Health and Welfare. Available
at: http://www.socialstyrelsen.se/lists/artikelkatalog/attachments/18085/2010-6-
29.pdf
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Independent variables
Multimorbidity was estimated using the Johns Hopkins
Adjusted Clinical Groups (ACG) Case-Mix System, a
system based on the theory that clustering of morbidity
is a better predictor of healthcare costs than the pres-
ence of specific diagnoses. By using different building
blocks every individual is, at the end, assigned a certain
ACG, which corresponds to a certain need for healthcare
resources. The system is based on the patients’ diagnoses
recorded during a defined period of time. The etiology,
duration, severity, method of diagnosis, treatment and
need of specialised care are considered for each of the
patients’ diagnoses. The ACGs may furthermore be clus-
tered into Resource Utilization Bands (RUBs). Individ-
uals without need of health care according to the ACG
Case-Mix system are placed in RUB 0, and individuals
with a very high degree of need for healthcare resources
are placed in RUB 5. For example, preventive interven-
tions correspond to RUB 1, a single chronic diagnosis
could correspond to RUB 3 and a certain combination
of chronic diagnoses corresponds to RUB 4 or RUB 5. In
RUB levels 0–2 there ought to be no patients with
pharmacological treatment, and therefore the results
from RUB levels 0–2 are not reported in this study. The
ACG Case-Mix System has previously been described
[20–23]. Information on diagnoses were obtained from
the CDWÖ register during 2006.
We chose to define elderly patients as being 65 years
or older. The elderly patients were further divided into
65–79 years and 80 years and above.
We used income as a measure of socioeconomic sta-
tus, reflecting the economic conditions the patients lived
in at the time of the study. Education may also be used
as a socioeconomic variable, but data on this were in-
complete among the elderly patients. The individual dis-
posable income in the study population was divided into
quartiles, from the lowest to the highest with equal
number of individuals in each quartile. The individual
income includes earnings from employment and busi-
ness, and transfer income (e.g. pension payments etc.),
but not capital returns. Data on income were obtained
from Statistics Sweden.
Outcome variable
The proportion of patients with a correct diagnosis
linked to the prescription drug, i.e. the proportion of pa-
tients having indication for treatment, was the outcome.
Information about the use of prescription drugs at the
individual level was acquired from the Swedish Pre-
scribed Drug Register, which is maintained by the Na-
tional Board of Health and Welfare [24]. This register
collects information from the National Corporation of
Swedish Pharmacies (Apoteket AB) on prescription
drugs dispensed from the pharmacies. If a drug was
prescribed by a physician, but not collected by the pa-
tient, the drug will not be included in the Swedish Pre-
scribed Drug Register. In 2006 the National Corporation
of Swedish Pharmacies had a monopoly on sales of
prescription drugs, and all prescription drugs were
tracked through the National Corporation of Swedish
Pharmacies.
The Anatomical Therapeutic Chemical (ATC) classifi-
cation system was elaborated by WHO to enable inter-
nationally comparable studies on prescription drugs
[25]. Active substances are classified in different groups
according to the organ or system on which they act, and
their therapeutic, pharmacological and chemical proper-
ties. The drugs are divided into 14 main ATC groups,
and these groups are subsequently divided into five
levels.
Over-the-counter drugs were not included in this
study.
Statistics
We used a report from the Swedish National Board of
Health and Welfare regarding pharmacological treat-
ment among elderly patients [15]. The report establishes
that having indications for the prescription drugs is fun-
damental for satisfactory pharmacological treatment, im-
plying that there is a purpose with the prescription. A
number of prescription drugs, for which it is particularly
important to have an accurate and up-to-date diagnosis,
are listed. These prescription drugs were selected by the
Swedish National Board of Health and Welfare since
there is a history of prescribing these drugs without a
correct indication and, furthermore, because adverse
drug reactions are highly associated with these drugs
among the elderly. We have used this list from the re-
port in our study. For every one of the selected prescrip-
tion drugs the diagnoses that were validated as accurate
were classified by using the Swedish database of pre-
scription drugs, containing information about indica-
tions for all approved prescription drugs in Sweden, see
Table 2 [26].
The proportion of patients with a correct diagnosis
linked to a prescription drug was analysed. The informa-
tion on diagnoses were obtained from the CDWÖ regis-
ter during 2005–2006. The data were furthermore
analysed in different strata: for males and females alone,
for different age levels, for each multimorbidity level and
for each income level. The outcome was compared using
chi2-test. Multimorbidity level 3 was compared with
multimorbidity levels 4 and 5 one by one, and income
level 1 was compared with income levels 2, 3 and 4 one
by one.
Logistic regression was used to examine the odds ratio
of having indication for the prescription drugs, giving
odds ratios (ORs) and 95 % confidence intervals (CIs).
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We generated a model that was adjusted for gender, age,
multimorbidity level and income level.
The list from the Swedish National Board of Health
and Welfare originally also contained cox-inhibitors
(NSAIDs), paracetamol and opioids, but since it is very
hard to tell which diagnoses that are validated as accur-
ate, not leaving any out, for example cancer or other
chronic painful diseases, we excluded these prescription
drugs from the analyses.
Results
The proportion of patients with a correct diagnosis
linked to the prescription drug was examined in the
study population, comprised by 77 978 individuals aged
65 years or older. Further characteristics are described
in Table 3. A total of 44 600 patients collected at least
one of the five examined prescription drugs.
On average 45.1 % (range 12.9 % – 75.8 %) of the pa-
tients’ dispensed drugs examined in this study had cor-
rect diagnoses, i.e. indications. Patients 80 years and
above had indication for the prescription drugs to the
lowest extent (40.8 %), and patients in RUB level 5 had
indication to the highest extent (52.2 %).
Antipsychotic drugs
Of the patients who used antipsychotic drugs 18.0 %
(467 of 2 601) had indication for these prescription
drugs. There was no difference between the genders or
between different multimorbidity levels (RUBs). There
was an age difference, where the oldest patients to a
lesser extent had indication for the dispensed antipsy-
chotics. There was also an income difference where the
poorest patients to a lesser extent had indication for
treatment (Table 4).
Patients 80 years and above had the lowest odds ratios
of having indication for treatment (OR 0.66 (CI 95 %
0.54-0.82)), and patients in the second highest RUB level
had the highest odds ratios of having indication for the
antipsychotic drugs (OR 3.93 (CI 95 % 2.29-6.75))
(Table 5).
Proton pump inhibitors
Of the patients who used proton pump inhibitors (PPIs),
12.9 % (1 674 of 13 002) had indication for the dispensed
PPIs. There was an age difference, where the oldest pa-
tients to a lesser extent had indication for the dispensed
Table 2 Prescription drugs for which an accurate and up-to-
date diagnosis is particularly important and their valid accurate
diagnoses, classified by using the Swedish database of
prescription drugs [26]
Prescription
drugs
ATCa codes Accurate diagnoses ICD-10b
codes
Antipsychotic
drugs
N05A
excluding
N05AN
Schizophrenia F22
F23
F24
F25
Bipolar disorder F31
Severe aggression in
Alzheimer’s disease
F91
G30/F00
Proton pump
inhibitors (PPIs)
A02BC Gastroesophageal
reflux
K21
Stomach ulcer K25
Ulcer in the duodenum K26
Ulcer in stomach or
duodenum
K27
Digoxin C01AA05 Heart failure I50
Atrial fibrillation I48
Loop diuretics C03C Pulmonary oedema J81
Heart failure I50
Hypertension I10
Oedema R60
Kidney failure N18
Liver failure K72
Serotonin reuptake
inhibitors (SSRIs)
N06AB,
N06AX
Depression F31
F32
F33
Social anxiety disorder F40
Panic disorder F41
Obsessive-compulsive
disorder
F42
aAnatomical Therapeutical Classification elaborated by the World Health
Organisation. Available at http://www.whocc.no/atcddd
bInternational Statistical Classification of Diseases and Related Health
Problems, 10th Revision
Table 3 Characteristics of the study population
Variables N (%)
Gender
Males 33994 (44 %)
Females 43983 (56 %)
Age
65-79 51945 (67 %)
80+ 26033 (33 %)
Multimorbidity level
3 35190 (45 %)
4 7107 (9 %)
5 2447 (3 %)
Income level
1 19495 (25 %)
2 19494 (25 %)
3 19494 (25 %)
4 19494 (25 %)
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PPIs. There were no differences in the rest of the sub-
groups (Table 4).
Patients 80 years and above had the lowest odds ra-
tios of having indication for treatment (OR 0.82 (CI
95 % 0.74-0.92)), and patients in the highest RUB level
had the highest odds ratios of having indication for
the dispensed PPIs (OR 2.99 (CI 95 % 2.07-4.31))
(Table 5).
Digoxin
Of the patients who used digoxin 75.8 % (2 395 of 3
161) had indication for the dispensed digoxin. There
were no differences in the subgroups (Table 4).
Patients in the second to lowest level of income had
the lowest odds ratios of having indication for treatment
(OR 0.84 (CI 95 % 0.66-1.06)), and patients in the high-
est RUB level had the highest odds ratios of having
Table 4 Proportion of patients with correct diagnoses linked to the prescribed drugs
Antipsychotics Proton pump inhibitors Digoxin Loop diuretics Serotonin reuptake inhibitors
Gender
Male 17.4 % (156/898) 12.9 % (664/5149) 78.2 % (1080/1381) 70.9 % (4581/6460) 39.2 % (1035/2641)
Female 18.3 % (311/1703) 12.9 % (1010/7853) 73.9 % (1315/1780) 67.9 % (6878/10137) 40.8 % (2570/6298)
Age
65-79 21.7 % (248/1143) 13.6 % (1077/7894) 78.2 % (921/1178) 69.5 % (4971/7157) 45.8 % (2130/4655)
80+ 15.0 %* (219/1458) 11.7 %* (597/5108) 74.3 % (1474/1983) 68.7 % (6488/9440) 34.4 %* (1475/4284)
Multimorbidity level
RUBa 3 (low) 20.7 % (258/1244) 14.3 % (1032/7234) 79.5 % (1327/1669) 71.3 % (6187/8683) 44.3 % (2042/4608)
RUB 4 23.8 % (114/479) 12.5 % (253/2028) 89.6 % (583/651) 81.2 %* (2439/3005) 46.3 % (688/1486)
RUB 5 (high) 19.6 % (46/235) 14.5 % (141/971) 93.5 % (272/291) 86.5 %* (1162/1344) 46.9 % (323/689)
Income level
1 (low) 13.4 % (128/953) 12.7 % (454/3577) 76.1 % (669/879) 68.8 % (3367/4895) 38.4 % (998/2602)
2 18.7 %* (159/851) 13.0 % (451/3481) 72.9 % (679/932) 67.4 % (3433/5092) 39.4 % (1054/2673)
3 24.4 %* (118/484) 13.1 % (427/3263) 76.3 % (595/780) 70.3 % (2893/4118) 42.6 % (881/2067)
4 (high) 19.8 %* (62/313) 12.8 % (342/2681) 79.3 % (452/570) 70.9 % (1766/2492) 42.1 % (672/1597)
aResource utilization band
*Significant difference in chi2-test, p < 0.05. Multimorbidity level 3 was compared with level 4 and 5 one by one. Income level 1 was compared with level 2, 3 and
4 one by one
Table 5 Odds ratio of having indication for treatment (full model)
Antipsychotics Proton pump inhibitors Digoxin Loop diuretics Serotonin reuptake inhibitors
OR (CI 95 %) OR (CI 95 %) OR (CI 95 %) OR (CI 95 %) OR (CI 95 %)
Gender
Male 1 1 1 1 1
Female 0.78 (0.62-0.98) 0.99 (0.89-1.11) 1.19 (0.98-1.45) 1.04 (0.97-1.12) 0.83 (0.75-0.91)
Age
65-79 1 1 1 1 1
80+ 0.66 (0.54-0.82) 0.82 (0.74-0.92) 0.85 (0.70-1.03) 0.97 (0.90-1.04) 0.61 (0.56-0.67)
Multi-morbidity level
RUBa 3 (low) 3.18 (1.90-5.32) 2.86 (2.07-3.96) 7.16 (5.31-9.67) 4.09 (3.60-4.65) 3.00 (2.47-3.65)
RUB 4 3.93 (2.29-6.75) 2.49 (1.76-3.52) 15.7 (10.8-22.8) 7.11 (6.11-8.26) 3.42 (2.76-4.23)
RUB 5 (high) 3.07 (1.69-5.56) 2.99 (2.07-4.31) 26.4 (15.4-45.4) 10.5 (8.63-12.8) 3.58 (2.81-4.55)
Income level
1 (low) 1 1 1 1 1
2 1.56 (1.20-2.02) 1.04 (0.90-1.19) 0.84 (0.66-1.06) 0.93 (0.85-1.02) 1.08 (0.97-1.21)
3 2.10 (1.57-2.80) 1.02 (0.88-1.18) 0.87 (0.67-1.12) 1.00 (0.91-1.11) 1.17 (1.04-1.33)
4 (high) 1.51 (1.06-2.13) 0.99 (0.84-1.16) 1.00 (0.74-1.34) 1.00 (0.89-1.12) 1.12 (0.98-1.29)
aResource utilization band
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indication for the dispensed digoxin (OR 26.4 (CI 95 %
15.4-45.4)) (Table 5).
Loop diuretics
Of the patients who used loop diuretics 69.0 % (11 459
of 16 597) had indication for the dispensed loop di-
uretics. Higher levels of multimorbidity among the pa-
tients were to a higher extent associated with indication
for treatment (Table 4).
Patients in the second lowest level of income had the
lowest odds ratios of having indication for treatment
(OR 0.93 (CI 95 % 0.85-1.02)), and patients in the high-
est RUB level had the highest odds ratios of having
indication for the loop diuretics (OR 10.5 (CI 95 % 8.63-
12.8)) (Table 5).
Serotonin reuptake inhibitors
Of the patients who used serotonin reuptake inhibitors
(SSRIs), 40.3 % (3 605 of 8 939) had indication for the
dispensed SSRIs. The oldest patients had to a lesser ex-
tent indication for the SSRIs. There were no differences
in the rest of the subgroups (Table 4).
Patients 80 years and above had the lowest odds ratios
of having indication for treatment (OR 0.61 (CI 95 %
0.56-0.67)), and patients in the highest RUB level had
the highest odds ratios of having indication for the dis-
pensed SSRIs (OR 3.58 (CI 95 % 2.81-4.55)) (Table 5).
Discussion
On average, less than half of the dispensed drugs had in-
dication for treatment, and there was considerable vari-
ation between the different ATC groups of prescription
drugs. Proton pump inhibitors were associated with the
lowest level of indication for treatment, and digoxin was
associated with the highest level of indication for treat-
ment. The oldest patients had the lowest odds ratios of
having indication for treatment, and patients with the
highest morbidity had the highest odds ratios of having
indication for treatment.
It is alarming that so few of the dispensed drugs had
correct indications. This is, however, consistent with
other studies, showing that between 44-57 % of the pa-
tients had at least one unnecessary drug, with lack of in-
dication as one of the most common reasons [27, 28].
One explanation for the very low level of indication
for the prescription drugs in this study could be that
physicians fail to register diagnoses on their patients. In
2005 and 2006 Östergötland County did not use ACG
Case-Mix for reimbursement. Thus, there was no finan-
cial, but only a medical incentive to register correct diag-
noses, which may have led to deficient registration of
diagnoses. Even though the registration may be satisfac-
tory, it is probably not totally complete, and therefore it
is likely that the results in this study to some extent may
be explained by substandard registration of diagnoses.
Poor planning, evaluation and ending of drug treat-
ment may, furthermore, explain the results. This may in
turn be an effect of the organisation of the Swedish
Healthcare System. In case of healthcare problems, pa-
tients in Sweden are supposed to get in contact with
their general practitioner (GP). However, patients may
seek secondary care without referral. Whenever this is
the case, the liability regarding the prescription of drugs
accompanies the patients, regardless of whether or not
the patient was referred. Elderly patients often have
many caregivers, for example primary healthcare centres,
acute care hospitals and rehabilitation departments [29].
Drug therapy is thus initiated at different levels of health
care. When non-GP caregivers initiate drug therapy, it is
not uncommon to assign the responsibility for evalu-
ation of the prescription drug effect to the patient’s GP.
In such cases of lacking continuity in the care of the pa-
tients it is important that information about the indica-
tion and expected effects, as well as whether the drug
therapy is temporary or continuous, is passed on to the
GPs. Unfortunately the communication concerning the
patients, when transferred between different caregivers,
has been shown to be inadequate [30]. Nevertheless, it is
hard for any physician to evaluate the effect of a pre-
scription drug not initiated by them, and it is not strange
to assume that GPs feel uncertain about evaluating pre-
scription drugs initiated by specialists and vice versa, sit-
uations that may lead to unnecessary drug therapy.
Increased stress in the health care system and shorter
patients consultations [31] may contribute to poorer
evaluation and ending of drug therapy [32]. In particular,
when it comes to ending drug therapy the physician
needs to allocate time to inform the patient about pos-
sible scenarios and any follow-up, and this should, fur-
thermore, be well planned to ensure that the patient
could turn to the physician in case of any issues or
questions.
It is worrisome that the oldest patients in the study
population had the lowest odds ratios of having indica-
tion for their prescription drugs, since this may lead to
unnecessary treatment, and, if the patient use many pre-
scription drugs, preventable polypharmacy. Polyphar-
macy may be defined as using at least five drugs on a
daily basis [33]. It increases the risk of adverse drug
events (ADEs) [34], which includes side effects of pre-
scription drugs, lack of effect and interactions between
different prescription drugs, and, furthermore, poly-
pharmacy increases the risk of inappropriate prescrib-
ing [35]. These effects altogether increase the medical
care need, which at worst could lead to hospital admis-
sions [36, 37]. Pharmacological treatment of elderly
patients needs to be handled with special care. Elderly
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patients, who often have a high level of multimorbidity,
should probably not be treated according to all clinical
protocols and guidelines associated with their diagnoses
because of the great risk of developing polypharmacy.
Instead physicians need to consider the context the eld-
erly patients live in, together with the overall clinical
situation, and plan the pharmacological treatment ac-
cording to this, an approach that would likely lead to
more satisfactory pharmacological treatment among the
elderly [38, 39].
Proton pump inhibitors (PPIs) were associated with
the lowest level of indication. Only 12.9 % of the pre-
scribed PPIs had an indication. PPIs have in former
studies been highly associated with inappropriate pre-
scribing among the elderly with lack of indication as the
major problem [40, 41]. In another study 85.8 % of the
prescribed PPIs lacked indication, which is fully consist-
ent with our results [42]. PPIs are associated with lack of
indication to such a high extent that one may suppose
that there is a widespread off-label use of this prescrip-
tion drug. One example of this could be prescription of
PPIs together with NSAIDs, acetylsalicylic acid and ste-
roids, to reduce the risk of developing ulcer in the stom-
ach or duodenum.
Serotonin reuptake inhibitors (SSRIs) and anti-
psychotic drugs have the lowest odds ratios of having in-
dication for treatment among the oldest patients. Both
SSRIs and antipsychotics have in previous studies been
associated with high levels of inappropriate prescribing
[43, 44]. One explanation for this may be a pronounced
off-label prescribing, which is supported by a French
qualitative study, where GPs were found to prescribe
SSRIs for a wide range of diagnoses other than depres-
sion and anxiety disorders [45]. A clinical observation
that may further partly explain the low level of indica-
tion for SSRIs is that patients using SSRIs and not hav-
ing any side effects are perceived to be quite reluctant to
discontinue their prescription drug, which may contrib-
ute to a low level of indication for treatment.
Limitations
This study is highly dependent on a reliable registration
of diagnoses. As mentioned before, substandard registra-
tion of diagnoses would lead to lower levels of indication
for treatment, with the risk of overestimating the lack of
indication for treatment. To increase the reliability we
included information about the registered diagnoses for
two years. There is furthermore a risk that patients who
had a consultation in late December 2004 did not collect
their prescription drugs at the pharmacy until January
2005. In this case the collected prescription drug(s)
would improperly be categorised as without correct indi-
cation, since the diagnoses are registered in 2004.
We have used a well-characterized data set, which
have been used in many other studies. Changing pre-
scribing patterns has been proven to be quite hard, even
in cases when efforts have been made to accomplish a
change [46, 47]. There has been no such effort in Öster-
götland County, from where the data are collected, and
thus there is no reason to believe that the results differ
from today.
The information on prescription drugs from the
Swedish Prescribed Drug Register contains information
on prescription drugs dispensed from the pharmacies
and should not be confused with drugs actually pre-
scribed by the physicians. Because of the risk of non-
adherence, i.e. patients do not collect all of their
prescription drugs from the pharmacies, there is a risk
that the results on lack of indication in this study are
underestimated.
In this study we were not able to examine the off-label
use of the studied prescription drugs. High levels of off-
label use, which as stated above has been reported for
both PPIs and SSRIs, may have led to lower levels of
indication for treatment, but at the same time not neces-
sarily to unjustified pharmacological treatment.
It would have been interesting to examine inappropri-
ate prescription following the Beers Criteria, even
though it is beyond the scope of this study, but we had
no access only to data from the CDWÖ register, con-
taining no information on Beers Criteria. Furthermore
we had no access to the longitudinal data required to re-
late health outcomes or adverse drug reactions to the
outcome.
Conclusion
On average, less than half of the studied prescription
drugs had indication for treatment. The quality was
highest in relation to multimorbidity and lowest in rela-
tion to age, with the lowest rates and odd ratios of hav-
ing indication for treatment among the oldest patients.
Since lack of quality of prescription drug use is highly
associated with inconvenience among the elderly, as well
as high costs to society, it is important that future re-
search and allocation of resources focus on the quality
of elderly patients’ drug therapy. In the end, this could
for example lead to complete and up-to-date prescrip-
tion drug lists, longer doctors visits for elderly patients
and more time for evaluation of prescription drug use
among elderly patients.
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